ConductScience.org, home

Paper28299742

Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.

Choi JY and 1 other. Methods Mol Biol, 2017. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors. Papers, record 28299742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28299742

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.
PubMed
Journal
Methods Mol Biol
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.08
iCite
Revised in PubMed
2020-02-25
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Choi JYJun Yong
2Fuerst RRita

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Matrix Metalloproteinase InhibitorsMajor topic
Molecular Docking SimulationMajor topic
Small Molecule LibrariesMajor topic
Binding Sites
Computational Biology
Crystallography, X-Ray
Drug Evaluation, Preclinical
High-Throughput Screening Assays
Matrix Metalloproteinase 13
Models, Molecular
Protein Conformation
Structure-Activity Relationship

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110437989New drugs on the horizon: matrix metalloproteinase inhibitors.Stem Cells1999https://conductscience.org/library/papers/10437989PubMed
211254383Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.J Mol Biol2001https://conductscience.org/library/papers/11254383PubMed
311274893Drug-like properties and the causes of poor solubility and poor permeability.J Pharmacol Toxicol Methods2000https://conductscience.org/library/papers/11274893PubMed
414711306Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.J Med Chem2004https://conductscience.org/library/papers/14711306PubMed
515027865Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.J Med Chem2004https://conductscience.org/library/papers/15027865PubMed
615667143ZINC--a free database of commercially available compounds for virtual screening.J Chem Inf Model2005https://conductscience.org/library/papers/15667143PubMed
715734645Structural basis for the highly selective inhibition of MMP-13.Chem Biol2005https://conductscience.org/library/papers/15734645PubMed
816492144Structural interaction fingerprints: a new approach to organizing, mining, analyzing, and designing protein-small molecule complexes.Chem Biol Drug Des2006https://conductscience.org/library/papers/16492144PubMed
916675286Structure-based virtual screening of chemical libraries for drug discovery.Curr Opin Chem Biol2006https://conductscience.org/library/papers/16675286PubMed
1017623656Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.J Biol Chem2007https://conductscience.org/library/papers/17623656PubMed
1118251495Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.J Med Chem2008https://conductscience.org/library/papers/18251495PubMed
1218289056Joint diseases and matrix metalloproteinases: a role for MMP-13.Curr Pharm Biotechnol2008https://conductscience.org/library/papers/18289056PubMed
1319378467Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells.Toxicology2009https://conductscience.org/library/papers/19378467PubMed
1419399780AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.J Comput Chem2009https://conductscience.org/library/papers/19399780PubMed
1519422229Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.J Med Chem2009https://conductscience.org/library/papers/19422229PubMed
1619516266Stromal expression of MMP-13 is required for melanoma invasion and metastasis.J Invest Dermatol2009https://conductscience.org/library/papers/19516266PubMed
1720196103Selective MMP13 inhibitors.Med Res Rev2011https://conductscience.org/library/papers/20196103PubMed
1820450209Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments.J Chem Inf Model2010https://conductscience.org/library/papers/20450209PubMed
1920481653Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.Drugs2010https://conductscience.org/library/papers/20481653PubMed
2020929257Quo vadis, virtual screening? A comprehensive survey of prospective applications.J Med Chem2010https://conductscience.org/library/papers/20929257PubMed

See all 32 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MMP134322PubTator's text mininghttps://conductscience.org/library/genes/4322

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28299742

GET https://conductscience.org/api/papers/v1/28299742/references?page=2